All In MedTech

Device Trial Radar · NCT07825558

A Study of the Jovi Patch, Powered by Signal Relief, for the Improvement of General Menstrual Discomfort

Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

May 8, 2026

Primary completion

Jun 2027

Study completion Jul 2027

Sponsor

Lead sponsor
Signal ReliefNot on our public-company list
Sponsor type
Industry
Collaborators
Holy Redeemer Hospital
First posted
Sep 17, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, care provider, investigator)
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
Female only, from 18 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot study is testing whether a thin, flexible, drug-free patch called the Jovi Patch (powered by Signal Relief) can help reduce general menstrual discomfort (pain and related symptoms during periods). The patch contains no medication, wires, or batteries. It uses special micro-metal particles that are thought to interact with the body's natural electrical signals related to pain. Researchers will compare an active version of the patch to a look-alike sham (inactive) patch. About 50 pre-menopausal women ages 18-50 who have menstrual discomfort (pain score greater than 4 on a 0-10 scale) will be randomly assigned to one of two groups: Active patch group (larger group) Sham patch group Participants will wear their assigned patch during six menstrual cycles (starting the day before their period begins and continuing through the week of flow). After three cycles, women in the sham group will switch to the active patch for the remaining three cycles so researchers can also look at the effects of switching. The main question is whether more women using the active patch achieve at least a 30% reduction in their pain scores compared with those using the sham patch. The study will also track changes in how much menstrual symptoms interfere with daily life, use of pain medications, and any side effects (such as skin irritation). Participation lasts through six menstrual cycles. The overall study is expected to take up to 12 months.

Conditions

  • General Menstrual Discomfort

Interventions

  • Jovi PatchDevice

    Non-invasive, drug-free flexible wellness patch containing conductive particle arrays

  • Sham PatchDevice

    Matching inactive (sham) patch that is identical in appearance to the active Jovi Patch but does not contain the conductive particle arrays

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants Achieving at Least 30% Change in NPRS ScoreTime frame: Baseline to end of treatment (after 6 menstrual cycles)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Redeemer Health

    Meadowbrook, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.